N-alkylimidazolium Salts Functionalized with p-Coumaric and Cinnamic Acid: A study of their antimicrobial and antibiofilm effects

Article abstract of DOI:10.3390/molecules24193484

The bacterial resistance to antibiotics has compromised the therapies used for bacterial infections. Nowadays, many strategies are being carried out to address this problem. Among them, the use of natural compounds like cinnamic and p-coumaric acids stands out. Nevertheless, their utilization is limited because of their unfavorable physicochemical properties. Due to the lack of new therapeutic alternatives for bacterial infections, novel strategies have emerged, such as the use of ionic liquids; given that they can show a broad spectrum of antibacterial activity, this is why we herein report the antibacterial and antibiofilm activity of a series of N-alkylimidazolium salts functionalized with p-coumaric and cinnamic acids. The results from this study showed better antibacterial activity against Gram-positive bacteria, with a predominance of the salts derived from coumaric acid and a correlation with the chain length. Additionally, a lower efficacy was observed in the inhibition of biofilm formation, highlighting the antibiofilm activity against Staphylococcus aureus, which decreased the production of the biofilm by 52% over the control. In conclusion, we suggest that the salts derived from p-coumaric acid are good alternatives as antibacterial compounds. Meanwhile, the salt derived from cinnamic acid could be a good alternative as an antibiofilm compound.

Full text of DOI:10.3390/molecules24193484

molecules
Article
N-alkylimidazolium Salts Functionalized with
p-Coumaric and Cinnamic Acid: A Study of Their
Antimicrobial and Antibiofilm Effects
Oscar Forero-Doria 1 , Ramiro Araya-Maturana 1,2 , Anggela Barrientos-Retamal 1,
Luis Morales-Quintana 3 and Luis Guzmán 4,
*
1
Instituto de Química de Recursos Naturales, Universidad de Talca, P.O. Box 747, Talca 3460000, Chile;
oforero@utalca.cl (O.F.-D.); raraya@utalca.cl (R.A.-M.); anggela.br@gmail.com (A.B.-R.)
Programa de Investigación Asociativa en Cáncer Gástrico (PIA-CG), Universidad de Talca,
Talca 3460000, Chile
Multidisciplinary Agroindustry Research Laboratory, Instituto de Ciencias Biomédicas,
Universidad Autónoma de Chile, Talca 3460000, Chile; luis.morales@uautonoma.cl
Departamento de Bioquímica Clínica e Inmunohematología, Facultad de Ciencias de la Salud,
Universidad de Talca, P.O. Box 747, Talca 3460000, Chile
2
3
4
*
Correspondence: lguzman@utalca.cl; Tel.: +56-71-2200-490
Academic Editor: Manuel Simões
Received: 4 September 2019; Accepted: 19 September 2019; Published: 26 September 2019
ꢀꢁꢂꢀꢃꢄꢅꢆꢇ
ꢀꢁꢂꢃꢄꢅꢆ
Abstract: The bacterial resistance to antibiotics has compromised the therapies used for bacterial
infections. Nowadays, many strategies are being carried out to address this problem. Among them,
the use of natural compounds like cinnamic and p-coumaric acids stands out. Nevertheless,
their utilization is limited because of their unfavorable physicochemical properties. Due to the lack of
new therapeutic alternatives for bacterial infections, novel strategies have emerged, such as the use of
ionic liquids; given that they can show a broad spectrum of antibacterial activity, this is why we herein
report the antibacterial and antibiofilm activity of a series of N-alkylimidazolium salts functionalized
with p-coumaric and cinnamic acids. The results from this study showed better antibacterial activity
against Gram-positive bacteria, with a predominance of the salts derived from coumaric acid and a
correlation with the chain length. Additionally, a lower efficacy was observed in the inhibition of
biofilm formation, highlighting the antibiofilm activity against Staphylococcus aureus, which decreased
the production of the biofilm by 52% over the control. In conclusion, we suggest that the salts derived
from p-coumaric acid are good alternatives as antibacterial compounds. Meanwhile, the salt derived
from cinnamic acid could be a good alternative as an antibiofilm compound.
Keywords: Antibiofilm effects; antimicrobial agents; cinnamoylimidazole salts; ionic liquids
1. Introduction
Many applications and innovations have been reported in the field of ionic liquids (ILs), which are
salts composed of ions that exist in the liquid state at room temperature [1]. Normally, they are formed
by organic cations that are linked with an organic or inorganic anion [ ]. Most cations have an aromatic
2
structure with nitrogen atoms in the aromatic ring, nitrogen heterocycles, while the anions usually
show a higher diversity [3].
ILs have been used in different areas with multiple applications for both production and
technological processes; for example, in chemistry, fundamental advances have been obtained by
synthetic chemistry, producing an electro-colloidal interface; in biology, ILs have found use in enzymatic
and cell biocatalysis, for protein stabilization and biodiesel production; and in physics and technology,
Molecules 2019, 24, 3484; doi:10.3390/molecules24193484
www.mdpi.com/journal/molecules

Molecules 2019, 24, 3484
2 of 13
ILs have been used in batteries and solar panels [
4]. In recent years, the use of ILs as drug-releasing
agents and in combination with pro-drugs has opened up new possibilities in the treatment of
diseases [5,6].
It has been shown that ILs exhibit antibacterial activity, which may be attributable to one or both
ions, giving rise to double-acting antimicrobial ILs [
they act as antimicrobials is still unknown. IL solutions share structural and mechanical analogies
with established biocides and cationic surfactants, such as quaternary ammonium compounds [ ].
6]; however, the mechanism of action by which
7,8
The common characteristics of a hydrophilic head group with one or more hydrophobic “tails”
observed in both ILs and cationic surfactants (benzalkonium chloride, chloride/cetylpyridinium
bromide, or cetrimonium bromide), suggest a common mechanism of action, which would be alteration
of the integrity of the cell membrane. These similarities extend towards a tendency for ILs to
aggregate in solution, forming micelles and presenting surface tension, observed when increasing the
lipophilicity [7,9,10], commonly tuned through the alkyl chain substituent [11].
The occurrence of multiple resistance to penicillin, methicillin, and other agents has compromised
the therapies used for bacterial infections [12]. The pathogens in which there has been an increase
in the resistance to antibiotics are Staphylococcus aureus, Enterococcus spp., Pseudomonas aeruginosa,
Escherichia coli, and Klebsiella spp. [13]. Additionally, these bacteria can form a biofilm, which is an
aggregate of organized microorganisms that live inside an extracellular polymeric matrix produced
by them, colonizing an inert surface or a living tissue [14]. This is a prokaryotic survival strategy,
which gives the bacteria significant advantages, since it provides protection against environmental
fluctuations of humidity, temperature, and pH, as well as protecting them against the efficacy of
antibiotics [15].
Different strategies have been carried out to face the continuous increase in the resistance to
antibiotics; one of these is the use of naturally occurring antimicrobial compounds, among which
the use of cinnamic and coumaric acid stands out. Cinnamic acid is a natural phenolic compound
present in various plant sources [16]. p-coumaric acid can be present as a free acid or in an esterified
form in many vegetables, fruits, and graminaceous plants [17]. Both compounds have shown
antibacterial activity against different bacterial strains [18–20]. Nevertheless, despite these activities,
their utilization is limited because of their unfavorable physicochemical properties, especially their
very poor water-solubility and low redox stability [21,22].
Given that ILs can show a broad spectrum of activity, affecting Gram-positive and -negative bacteria,
the aim of this work was to determine the antibacterial and antibiofilm activity of N-alkylimidazolium
salts functionalized with p-coumaric and cinnamic acid, and to evaluate the minimum inhibitory
concentration (MIC) of these derivatives with different chain lengths and their action on the formation
of a biofilm in pathogenic bacteria.
2. Results and Discussion
2.1. Chemistry
The synthesis of N-cinnamoyl salts (7a
the synthesis of N-cinnamoyl salts was the production of amides 3a
3a , we tested the reaction of 1,1-carbonyldiimidazole (CDI) ( ) with p-coumaric acid 1b in a 1:1
–
c
and 8a
–
c
) is shown in Scheme 1. The first step for
–
b. In an attempt to obtain
–
b
2
equivalent molar ratio (Scheme 2). Briefly, the reaction mixture, with THF as the solvent and under
nitrogen atmosphere, was refluxed (4 h) and its progress was monitored by TLC. The TLC plates
showed multiple spots in the reaction mixture; the GC-MS analysis of the reaction crude evidenced the
formation of 3b and 9 with 40% and 30% conversion, respectively.
One of the reasons for the low yield presented in the formation of amide 3b was the formation of
by-product
9 due to the nucleophilic nature of the -OH phenolic present in the p-coumaric acid 1b.
Cappelli et al. [23] reported the formation of this by-product in the construction of hyaluronic acid

Molecules 2019, 24, 3484
3 of 13
derivatives. The researchers used 2 eq of CDI for the construction of 3b, resulting in the formation of
the latter together with 9 (Scheme 2).
Scheme 1. Synthesis of imidazolium salts derived from hydrocinammic-imidazol derivatives 7a
and 8a–c.
–c
Scheme 2. Synthesis in the condensed phase of p-coumaric-imidazol derivative 3b.
Due to the low yield obtained in the formation of 3b and the formation of by-product (9), the search
for an efficient methodology for the construction of these amides was imperative. Verma et al., 2012 [24],
reported the synthesis of a series of amides using CDI in solvent-free conditions. This methodology
consists of macerating the corresponding acid with the CDI to obtain different acyl imidazoles;
key intermediates in obtaining amides without the use of any dry organic solvent and in inert
atmosphere for an average time of 5–10 min. Based on the experimental evidence previously described
and motivated by the use of green approaches in our synthetic plan, we used this mechanochemical
synthesis for the construction of amides 3a
–b (Scheme 1). The grinding reaction of the hydroxycinnamic
acids 1a with CDI was carried out in a 1:1 equivalent ratio, in a mortar grinder (FRITSCH: Pulverisette
–
b

Molecules 2019, 24, 3484
4 of 13
2) for 20 min, which produced a viscous yellow oil for the cinnamic acid 1b, and the derivative obtained
from cinnamic acid 1a was a colorless oil; the reactions were monitored by TLC until total consumption of
the reagents was reached. Subsequently, the resulting amides were purified by column chromatography
(CC) using a DCM/MeOH 95:5 elution mixture. The obtained amides 3a (74%) and 3b (92%) showed
excellent yields, without the formation of by-products. It is important to highlight the regioselectivity in
the amidation of 1b, since the amide was obtained on the acid group and the formation of the carbamate
9
was not observed. In this sense, Patil et al. (2008) described the regioselective 6-O-tritylation/silylation
(etherification) of methyl -d-glucopyranoside or their derivatives under solvent-free conditions by
α
planetary ball milling (dry grinding) [25]. Finally, the reaction of 3a and 3b with alkyl bromides (hexyl,
octyl, and decyl chain lengths) was carried out in microwave and solvent-free conditions, as was
described in a previous work [26].
The end of the reaction was the obtention of the salts 7a
viscous oil; toluene was decanted to remove any unreacted starting materials and solvents, allowing this
phase to be isolated. Subsequently, the viscous oil was rinsed with diethyl ether (4 3 mL), and the
latter layer was then separated by decantation and placed in a high vacuum for 4 h to obtain the salts
7a . On the other hand, the formation of the salts 8a took place adequately. Chromatographic
–c, marked by the separation of colorless
×
–
c
–c
purification was carried out using Hexane/EtOAc 7:3 and the salts were obtained as creamy solids.
The yields and experimental considerations are discussed in the experimental part of this paper.
2.2. Determination of the Minimum Inhibitory Concentration (MIC) by Microdilution in a 96-Well Plate
The MIC value was reported as the last dilution in which no bacterial viability was observed,
using the redox indicator 2,3,5-triphenyltetrazolium chloride (Figure 1).
Figure 1. Minimum inhibitory concentration (MIC) determination by microdilution in a 96-well plate.
The line indicates the last dilution where bacterial viability was not evidenced. Columns (1–12): different
N-alkylimidazolium salts (in duplicate). Rows (A–H): seriated dilutions of each salt (2 - 0.015626 mM).
None of the precursors studied (3a and 3b), at the concentrations used, showed antibacterial
activity (Table 1). In Gram-positive bacteria (S. aureus and S. epidermidis), the salts derived from
cinnamic acid showed a correlation between the antibacterial activity and the length of the alkyl chain,
with a lower MIC being obtained as the alkyl chain increased. By adding a hydroxyl group to the
molecule (coumaric acid), an improvement in the antibacterial activity was seen in the salts that had
an alkyl chain of 8 and 10 carbons (four and two times, respectively) in comparison with those that
did not possess the modification and had the same length of the chain; however, no difference in the
antibacterial activity was seen when the alkyl chain had six carbons.
In Gram-negative bacteria, minimal antibacterial activity was observed against P. aeruginosa,
with an MIC value of over 2 mM in both cases. In the case of the antibacterial activity against
Acinetobacter baumannii, the same MIC was observed in the salts with six carbons; nevertheless, a better
effect was observed in the salts with a chain length of 8 and 10 carbons without a hydroxyl group,
contrary to what was observed in Gram-positive bacteria.

Molecules 2019, 24, 3484
5 of 13
Table 1. Minimum inhibitory concentration (MIC) of Gram-positive and Gram-negative bacteria.
S. aureus
S. epidermidis
A. baumannii P. aeruginosa
µM
3a
7a
7b
7c
3b
8a
8b
8c
>2000
2000
250
>2000
2000
125
31.25
>2000
1000
31.25
<15.625
>2000
2000
250
>2000
>2000
>2000
2000
>2000
>2000
2000
62.5
250
>2000
2000
62.5
>2000
2000
1000
500
31.25
1000
Since there is a great variety of etiological agents that cause bacterial infections and the emergence
of multiple resistance to antibiotics, where the main ones would be the Gram-positive bacteria
(S. aureus, S. pyogenes, and Staphylococcus coagulase negative), followed by the Gram-negative bacteria
(Enterobacteria and non-fermenting bacilli) [27], correct identification of the pathogenic species,
in addition to the study of antibiotic susceptibility, becomes essential. Additionally, biofilm production
of the bacteria involved must be considered, since it is estimated that 65% of bacterial infections are
associated with a bacterial biofilm [28].
As seen in other studies, imidazole-based ILs have shown good antimicrobial activity. Docherty and
Kulpa, 2005, tested the toxicity and antimicrobial activity of ILs derived from imidazole, which exhibited
significant antimicrobial activity in pure cultures of E. coli, S. aureus, B. subtilis, P. fluorescens,
and S. cerevisiae [29]. Wei, et al., 2012, evaluated the antimicrobial activity of 23 cinnamoyl derivatives
against B. subtilis, E. coli, and S. cerevisiae, showing that most of them display good antimicrobial
activity against these microorganisms, especially against S. cerevisiae [30].
In this work, it was evidenced that the alkyl chain in the structure is mandatory to obtaining
antibacterial activity at the concentrations used. The salts with chain lengths of 6, 8, or 10 carbons of the
alkyl substituent, showed antibacterial activity dependent of the length of the chain, which indicates
that the alkyl group significantly improves the antibacterial activity of ILs, as Luczak et al., 2010,
also showed in 1-alkyl-3-methylimidazole derivatives in which the antibacterial activity improved
when adding an alkyl chain [9].
Regarding the MIC values of the N-cinnamoyl salts synthesized, a resistance to most of them was
evidenced in P. aeruginosa at the concentration used. The same results were obtained by Santos et al.,
2014, who tested nine ILs containing an imidazole, colinium, or phosphonium cation, and showed that
P. aeruginosa was the most tolerant bacterium to imidazole-based IL, being the only microorganism
studied that grew in the presence of these ILs [31]. In S. aureus, S. epidermidis, and A. baumannii, it was
found that an increase in the length of the chain increased the antibacterial activity, with the 10-carbon
chain being the largest used in this work. In this respect, Garcia et al., 2014, evaluated the antimicrobial
activity of ILs with long chains (from 6 to 14 carbon atoms), with an amide functional group and a
cation of methylimidazole or pyridinium, against Gram-positive and Gram-negative bacteria and
fungi, showing that the ILs with more than 8 carbon atoms in the alkyl chain had a broad spectrum of
action [32]. This is consistent with the results obtained, since the salts with the longest chain (7c and
8c) presented the best antibacterial activity.
The antibacterial activity (measured as the MIC value) of the 10-carbon IL (7c) was 32 times better
than the salt with the alkyl chain of 6 carbons (7a) for S. aureus, 64 times better for S. epidermidis,
and 8 times better for A. baumannii (Table 1). Venkata et al., 2012, evaluated the antibacterial activity
of 1-alkyl-3-methylimidazole, which had better antibacterial activity against Gram-positive bacteria
(S. aureus) compared to Gram-negative bacteria (P. aeruginosa) [33], consistent with the results obtained
in this work. The salts that had a hydroxyl group in their structure (p-coumaric derivative) improved
the antibacterial activity against Gram-positive bacteria, decreasing the MIC value up to four times

Molecules 2019, 24, 3484
6 of 13
compared with the salts with no hydroxyl group. For example, salt 8b presented a better activity
against S. aureus and S. epidermidis. On the contrary, in Gram-negative bacteria, the addition of the
hydroxyl group decreased the antibacterial activity, showing higher MIC values (up to four times
higher), as in the case of 8c in A. baumannii. This could be due to differences in the cell wall of
Gram-positive and Gram-negative bacteria, so further studies should be carried out to determine the
cause of these differences with the addition of a hydroxyl group.
Due to the best correlation between the antibacterial activity and the length of the chain being
observed in the molecules with an eight-carbon chain length (7b and 8b), these were used to test the
antibiofilm activity against Staphylococcus aureus, Staphylococcus epidermidis, and Acinetobacter baumannii.
Because of the high resistance presented by P. aeruginosa to the salts at the concentration used, the
antibiofilm activity in this bacterium was not tested.
2.3. Determination of Antibiofilm Activity in 96-well Plates
The antibiofilm activity was calculated by the formation of a biofilm, comparing the absorbances
measured in the wells that had the salt with the absorbance measured in the positive control, which
was considered 100% biofilm formation (Table 2).
Table 2. Percentage (%) of inhibition of biofilm formation.
S. aureus
S. epidermidis
A. baumannii
MIC × 2
MIC × 1/2
MIC × 2
MIC × 1/2
MIC × 2
MIC × 1/2
7b
8b
52 ± 4% **
20 ± 6%
28 ± 5%
3 ± 2% ***
34 ± 4% *
1 ± 0.8% *
34 ± 3%
33 ± 7%
35 ± 6%
33 ± 6%
20 ± 5%
20 ± 4%
* p < 0.05; ** p < 0.01, and *** p < 0.001 against 8b.
In S. aureus, inhibitory activity of the biofilm was evidenced by over 50% (CMI
not having a hydroxyl group, which was statistically higher than the salt with the hydroxyl group,
while minor activity was found in MIC 1/2, with no differences among them. On the other hand,
no differences were observed between the salts at a concentration of MIC 2 in S. epidermidis; however,
a total loss of activity was found in 7b at a concentration of MIC 1/2, and a similar situation was
2, the salt 7b presented a percentage
×
2) of the salt
×
×
×
found in A. baumannii. Nevertheless, at a concentration of CMI
of inhibition of the biofilm statistically higher than that of 8b.
×
The results showed a lower efficacy compared with the antibacterial activity, since the formation
of a biofilm at the concentration used (MIC 1/2) was not completely inhibited. Ferrer et al., 2017,
×
analyzed the effect of ten antibiotics on the biofilm formation of clinical isolates of S. aureus and
S. epidermidis, showing that, in some of the antibiotics, using sub-inhibitory concentrations, the formation
of a biofilm was even stimulated [34]. In 8b, no significant variation in biofilm formation was observed
in any of the bacteria, for both concentrations used. Nevertheless, when 7b was used at a concentration
equivalent to twice the MIC, an inhibition in the formation of biofilm was observed, being higher in
S. aureus, decreasing the production of biofilm by 52%. Venkata et al., 2012, evaluated the antibiofilm
activity of 1-dodecyl-3-methylimidazole in S. aureus and P. aeruginosa, and obtained better antibiofilm
activity against Gram-positive bacteria than Gram-negative [33], which is consistent with our results,
where it was observed that the antibiofilm activity was better in S. aureus. More studies on the
antibiofilm activity of these salts are required, since, due to the absence of previous reports of ILs equal
to those used in this investigation, there is no point of comparison.
2.4. Molecular Dynamic (MD) Simulations Analysis
Molecular dynamic (MD) simulations for the two salts in the phosphatidyl oleoyl
phosphatidylcholine (POPC) lipid bilayer were performed to study their putative incorporation
into or interaction with the lipid phase. According to the antibacterial screening and biological activity

Molecules 2019, 24, 3484
7 of 13
determinations, 7c and 8c with longer aliphatic chains were expected to be incorporated into the lipid
bilayer. When set at 20 Å, the distance between the ligand and the lipid center of mass immersed
ligands in bulk water. The salt 7c was highly mobile in relation to 8c, showing a higher value of RMSD,
which an average of 5.9 Å and 2.9 Å, respectively. Additionally, it was observed that the Br atom in
both salts was released/separated from the molecule, which was previous to the interaction with the
membrane in both MD simulations (See Videos S1 and S2). However, 7c showed a more unstable
interaction with respect to 8c, because the interaction with the membrane was discontinuous and only
occurred for a short time (Figure 2A). Meanwhile, the interaction of 8c was constant from the first ns
until the end of the MD simulation (Figure 2B and Video S2), even when it was on the surface (it was
not able to completely penetrate the membrane), similar to the case of the 7c molecule, which, in a short
period of time, at the end of the MD simulation (around 3 ns during 38 to 40 ns), partially interacted
with the bilayer (Figure 2A and Video S1). The incorporation of the 8c molecule in the bilayer probably
occurred via the passive diffusion phenomenon, but due to its lack of hydrophobicity (hydroxyl group
of the compound), it was not incorporated into the bilayer (Figure 2B). Therefore, 8c’s behavior was
similar to that of compound [CDIM]Cl (an ionic liquid with a longer alkyl chain) previously shown
by Forero-Doria et al. (2018) [24]. The authors showed, using MD simulations, how the [CDIM]Cl
molecule was incorporated into and remained in the bilayer, and they related this to passive diffusion
of the compound towards the membrane surface [24]. Additionally, we observed differences in the
distance between the mass center of the two salts with respect to the surface of the bilayer (Figure 2C);
8c was quickly oriented near the bilayer and for this reason, the distance was around 1 or 1.5 Å after
the first nanosecond of the MD simulations. Meanwhile, 7c showed a greater distance and even though
in small moments at the final of the MD simulation it approached the bilayer, this interaction was not
stable, causing the distance to be greater again (Figure 2C).
Figure 2. Interaction between 7c and 8c molecules with a lipid bilayer. Incorporation and interaction
of the 7c
simulation. In the figures (
visualization. ( ) Minimum distance obtained from two independent MD simulations, between the
mass center of the 7c and 8c molecules and the surface of the lipid bilayer.
(
A) and 8c
(
B) molecules in the membrane along with 40 ns of the molecular dynamic (MD)
A
) and ( ) over time, the water molecules were removed to improve
B
C

Molecules 2019, 24, 3484
8 of 13
2.5. In Silico ADME Properties of N-alkylimidazolium Salts 7a–c and 8a–c
The physical properties and the ADMET parameters (adsorption, distribution, metabolism and
excretion) of N-alkylimidazolium salts 7a and 8a were computed using the freely accessible web
–c
–c
server SwissADME (http://swissadme.ch/index.php#undefined).
The results of the in silico ADME properties of N-alkylimidazolium salts 7a–c and 8a–c are listed
in Table 3, and the results suggest that there are no significant violations of Lipinski’s rule of five since
all calculated physicochemical descriptors and pharmacokinetics properties are within the expected
thresholds (molecular weight (g/mol) = 198–435; MLogP = 1.12–4.45; HBA = 1–3; and HBD = 0–1).
The highly lipophilic character (MLogP > 4.15) of the compound 7c can be attributed to the chain
length of 10 carbon atoms, which may have made membrane penetration difficult, unlike 8c (MlogP =
3.87), which contained a hydroxyl group in its structure; the alkyl chain of 10 carbon atoms showed a
better interaction with the lipid bilayer.
Table 3. Physicochemical descriptor calculated by the SwissADME simulation.
Comp.
MW a
MlogP b
nHBA c
nHBD d
nRB e
TPSA (Å2) f
3a
7a
7b
7c
3b
8a
8b
8c
198.22
363.29
391.35
419.40
214.22
379.29
407.34
435.40
1.70
3.57
4.02
4.45
1.12
2.99
3.44
3.87
2
1
1
1
3
2
2
2
0
0
0
0
1
1
1
1
3
8
10
12
3
8
10
12
34.89
25.88
25.88
25.88
55.12
46.11
46.11
46.11
a
Molecular weight; b calculated lipophillicity (MLog Po/w); c number of hydrogen bond acceptors; d number of
hydrogen bond donors; e number of rotatable bonds; f topological polar surface area.
3. Materials and Methods
3.1. General Information
Reagents for synthesis were obtained from Sigma-Aldrich (St. Louis, MO, USA). 1H and 13C-NMR
spectra (400 MHz for proton and 100 MHz for carbon) were recorded on an AM-400 spectrometer
(Bruker, Rheinstetten, Germany). Mass spectrometry was conducted in a high-resolution mass
spectrometer ExactiveTM Plus Orbitrap (ThermoFisher Scientific, Bremen, Germany). Scan parameters
were as follows: Resolution: 140,000; AGC target: 3e6; max. inject time: 200; HESI source: sheath gas
flow; 10, aux. gas flow rate: 3; sweep gas flow rate: 0; capillary temp: 250 ◦C; S-lens RF level: 0; heater
temp: 50 ◦C.
3.2. Chemistry
3.2.1. General Procedure for N-cinnamoylimidazole Synthesis
Briefly, a mixture of cinnamic (1a) or p-coumaric (1b) acid (10 mmol) and CDI (10 mmol) was
subjected to grinding in a mortar grinder (FRITSCH: Pulverisette 2) at 70 rpm for 20 min, producing
viscous oils as products (3a–b). The oils obtained were subject to column chromatography with
DCM/MeOH 95:5 to produce a 74–92% yield.
3.2.2. General Procedure for the Synthesis of Different N-cinnamoylimidazolium Salts
The quaternization reaction was carried out by reacting the different N-cinnamoylimidazole
3a
microwave radiation (250 MW) at 80 ◦C for 10 min and solvent-free conditions. Subsequently, the
unreacted materials were removed by washing them with diethyl ether (4 10 mL), resulting in the
–b (1 mmol) with the different alkyl bromides (hexyl (4), octyl (5), and decyl (6)) (1.5 mmol) under
×

Molecules 2019, 24, 3484
9 of 13
crude of the reaction. Then, the residue was subject to column chromatography with Hexane/EtOAc
7:3 to produce a 40%–65% yield.
1
(E)-1-(1H-imidazol-1-yl)-3-phenylprop-2-en-1-one (3a). 74% yield. H-NMR (400 MHz, MeOD): 1H-NMR
(400 MHz, MeOD)
δ 7.76 (s, 2H), 7.49–7.37 (m, 2H), 7.23 (t, J = 8.5 Hz, 2H), 7.02 (s, 3H), 6.39 (d,
J = 16.0 Hz, 1H). 13C-NMR (100 MHz, MeOD)
δ 178.69, 143.87, 136.51, 130.75, 129.95, 129.89 (2C),
129.28, 128.86 (2C), 127.75, 122.33. HRMS (HESI/Orbitrap) m/z calculated for C12H10N2O+ [M + H+]:
199.0866; found 199.0870.
1
(E)-3-(4-hydroxyphenyl)-1-(1H-imidazol-1-yl)prop-2-en-1-one (3b). 92% yield. H-NMR (400 MHz, MeOD):
δ
7.66 (s, 1H), 7.19 (d, J = 15.9 Hz, 1H), 7.06 (d, J = 8.5 Hz, 2H), 6.84 (s, 2H), 6.46 (d, J = 8.6 Hz,
2H), 5.97 (d, J = 15.9 Hz, 1H). 13C-NMR (100 MHz, MeOD):
130.77 (2C), 127.63, 122.02, 117.97, 116.75 (2C). HRMS (HESI/Orbitrap) m/z calculated for C12H10N2O2
[M + H+]: 215.0815; found 215.0820.
δ
172.81, 160.72, 144.98, 136.01, 132.37,
+
1
1-cinnamoyl-3-hexyl-1H-imidazol-3-ium bromide (7a). 50% yield. H-NMR (400 MHz, MeOD)
δ
8.01 (s,
1H), 7.63 (d, J = 16.0 Hz, 1H), 7.57 (d, J = 4.6 Hz, 2H), 7.38 (m, 3H), 7.26 (s, 1H), 7.13 (s, 1H), 6.47 (d,
J = 16.0 Hz, 1H), 4.11–4.02 (m, 2H), 1.80 (m, 2H), 1.29 (m, 6H), 0.88 (t, J = 6.1 Hz, 3H). 13C-NMR
(100 MHz, MeOD) δ 170.95, 159.13, 156.56, 145.72, 136.01, 131.24, 131.24, 129.97 (2C), 129.10 (2C), 120.17,
48.78, 32.33, 31.80, 27.13, 23.52, 14.25. HRMS (HESI/Orbitrap) m/z calculated for C18H23BrN2O+ [M+]:
283.1805; found 283.1820.
1
1-cinnamoyl-3-octyl-1H-imidazol-3-ium bromide (7b). 65% yield. H-NMR (400 MHz, MeOD)
δ
7.83 (s,
1H), 7.57 (d, J = 16.0 Hz, 1H), 7.53 (dd, J = 6.8, 1.4 Hz, 2H), 7.34 (m, 3H), 7.16 (s, 1H), 7.03 (s, 1H), 6.46 (d,
J = 16.0 Hz, 1H), 4.01 (t, J = 7.1 Hz, 2H), 1.84–1.66 (m, 2H), 1.35–1.15 (m, 10H), 0.85 (t, J = 6.6 Hz, 3H).
13C-NMR (100 MHz, MeOD)
δ 171.58, 144.98, 137.95, 136.20, 131.04, 129.94 (2C), 129.01 (2C), 127.52,
121.12, 121.03, 48.47, 32.87, 31.95, 30.24, 30.10, 27.49, 23.65, 14.39. HRMS (HESI/Orbitrap) m/z calculated
for C20H27BrN2O+ [M+]: 311.2118; found 311.2130.
1
1-cinnamoyl-3-decyl-1H-imidazol-3-ium bromide (7c). 60% yield. H-NMR (400 MHz, MeOD)
δ
7.86 (s,
1H), 7.63 (d, J = 16.1 Hz, 1H), 7.58 (d, J = 5.6 Hz, 2H), 7.39 (m, 3H), 7.21 (s, 1H), 7.07 (s, 1H), 6.49 (d,
J = 16.0 Hz, 1H), 4.05 (t, J= 7.1 Hz, 2H), 1.84–1.66 (m, 2H), 1.29 (s, 14H), 0.85 (t, J = 6.6 Hz, 3H). 13C-NMR
(100 MHz, MeOD) δ 171.27, 145.29, 139.38, 136.15, 131.12, 129.96 (2C), 129.05 (2C), 127.66, 120.99, 120.78,
49.29, 33.03, 31.97, 30.58 (2C), 30.39, 30.14, 27.49, 23.70, 14.41 HRMS (HESI/Orbitrap) m/z calculated for
C22H31BrN2O+ [M+]: 339.2431; found 339.2450.
(E)-1-(3-(4-hydroxyphenyl)acryloyl)-3-hexyl-1H-imidazol-3-ium bromide (8a). 40% yield. 1H-NMR (400 MHz,
MeOD)
δ 7.63 (s, 1H), 7.56 (d, J = 15.9 Hz, 1H), 7.42 (m, 3H), 6.79 (m, 3H), 6.27 (d, J = 15.9 Hz, 1H),
4.19 (t, J = 7.2 Hz, 2H), 1.95–1.80 (m, 2H), 1.32 (s, 6H), 0.89 (s, 3H). 13C-NMR (100 MHz, MeOD)
δ
171.34, 160.82, 145.85, 130.78 (2C), 127.22, 123.58, 116.60 (2C), 116.27, 50.70, 32.03, 30.83, 30.39, 26.86,
26.74, 23.29, 14.05. HRMS (HESI/Orbitrap) m/z calculated for C18H23BrN2O2+ [M+]: 299.1754; found
299.1770.
1
(E)-1-(3-(4-hydroxyphenyl)acryloyl)-3-octyl-1H-imidazol-3-ium bromide (8b). 45% yield. H-NMR (400 MHz,
MeOD)
δ 7.52 (s, 1H), 7.47 (d, J = 15.9 Hz, 1H), 7.33 (m, 3H), 6.70 (m, 3H), 6.19 (d, J = 15.9 Hz, 1H),
4.08 (t, J = 7.2 Hz, 2H), 1.77 (m, 2H), 1.29–1.07 (m, 10H), 0.78 (t, J = 6.3 Hz, 3H). 13C-NMR (100 MHz,
MeOD)
δ
171.52, 160.96, 145.92, 130.94 (2C), 127.41, 123.73, 116.78 (2C), 50.88, 32.84, 31.82, 31.04, 30.19,
30.07, 30.00, 27.45, 27.25, 23.63, 14.39. HRMS (HESI/Orbitrap) m/z calculated for C20H27BrN2O2 [M+]:
+
327.2067; found 327.2080.
1
(E)-1-(3-(4-hydroxyphenyl)acryloyl)-3-decyl-1H-imidazol-3-ium bromide (8c). 50% yield. H-NMR (400 MHz,
MeOD)
4.15 (t, J = 7.2 Hz, 2H), 1.84 (dd, J = 13.8, 6.9 Hz, 2H), 1.42–1.14 (m, 14H), 0.84 (s, 3H). 13C-NMR
(100 MHz, MeOD) 171.52, 160.99, 146.01, 130.96 (2C), 127.40, 127.04, 123.76, 116.78 (2C), 50.89, 33.01,
δ 7.59 (s, 1H), 7.53 (d, J = 15.9 Hz, 1H), 7.39 (m, 3H), 6.76 (m, 3H), 6.25 (d, J = 15.9 Hz, 1H),
δ

Molecules 2019, 24, 3484
10 of 13
31.04, 30.57, 30.54, 30.39, 30.12, 30.05, 27.47, 27.25, 23.70, 14.41. HRMS (HESI/Orbitrap) m/z calculated
for C22H31BrN2O2+ [M+]: 355.2380; found 355.2400.
3.3. Bacterial Strains
The bacterial strains were kept frozen in glycerol-lactose medium at
20 ◦C. The strains used were
−
Staphylococcus aureus (ATCC 25923), Staphylococcus epidermidis (ATCC 14990), Pseudomonas aeruginosa
(ATCC 27853), and Acinetobacter baumannii (ATCC 19606). Prior to the tests, they were seeded in brain
heart infusion (BHI) agar and incubated for 18 h at 37 ◦C, after which they were spiked in a BHI broth
and incubated for 18 h at 37 ◦C for metabolic activation of the microorganisms.
3.4. Determination of the Minimum Inhibitory Concentration (MIC) by Microdilution in a 96-Well Plate
The antibacterial activity of the different salts was evaluated by means of the 96-well plate
microdilution assay, a technique adapted from the methodology described by Eloff et al., 1998 [35].
The bacterial inoculum was obtained from a BHI broth previously adjusted to a McFarland 0.5 and
the concentration of the inoculum used for the test was a 1/10 dilution of this standard. The salts
were solubilized in sterile physiological saline (0.15 M) and its concentrations were adjusted to a final
well volume of 200
µL. Then, 100 µL of Mueller-Hinton broth and 100 µL of the corresponding salts
solution were added to each well in duplicate. The final concentrations of each salt used were 2 mM,
1 mM, 0.5 mM, 0.25 mM, 0.125 mM, 0.0625 mM, 0.03125 mM, and 0.015625 mM. A total of 10 µL of the
0.5 McFarland bacterial suspension diluted 1/10 was added to each well.
Bacterial growth controls (positive control) and the control of culture medium (negative control)
were included in each plate, and the plates were incubated for 18 h at 37 ◦C in continuous
agitation. Bacterial growth was revealed through the addition of 10
µL of the redox indicator
2,3,5-triphenyltetrazolium chloride (5 mg/mL) to each well. This sample was then incubated for 30 min
at 37 ◦C under agitation, and the reddish coloration obtained was measured at an absorbance of 600 nm
with a multi-plate reader. The results obtained from three independent experiments reported the
lowest concentration of a salt that prevents the visible growth of the microorganism (MIC).
3.5. Determination of Antibiofilm Activity in 96-Well Plates
The bacterial inoculum was obtained from a BHI broth previously adjusted to a McFarland 0.5
and the concentration of the inoculum used for the test was a 1/10 dilution of this standard. The salts
were solubilized in sterile physiological saline (0.15 M) and their concentrations were adjusted to a
final well volume of 200
µL. Then, 100
µL of Mueller-Hinton broth and 100
µL of the corresponding
salt solution were added to each well in duplicate.
A concentration corresponding to twice the MIC (MIC
each salt was used for each bacterium. A total of 10 µL of the 0.5 McFarland suspension diluted
×
2) and 50% of the MIC (MIC 1/2) of
×
1/10 was added to each well, bacterial growth controls (positive control) and the control of culture
medium (negative control) were included in each plate, and the plates were incubated for 18 h at 37 ◦C
without agitation.
To reveal the formation of biofilm, 20
m filter) was added to each well and incubated for 10 min at room temperature. Then, each well
was washed with PBS buffer three times, the plates were allowed to dry for 15 min, and 100 L of 95%
µL of 0.1% crystal violet solution (pre-filtered through a
0.44
µ
µ
ethanol was then added to each well, solubilizing the staining at room temperature. Finally, the content
of each well was mixed for a short time and the absorbance was measured at a wavelength of 600 nm,
in a Tecan Infinite® 200 Pro plate reader (Männerdorf, Switzerland).
Due to the MIC value against P. aeruginosa being above the maximum concentration used, it was
not included in this assay. Additionally, the salts 7b and 8b were used in the determination of
antibiofilm activity because they showed defined MIC values (except for P. aeruginosa). The differences
among these salts were obtained using one-way ANOVA with a Tukey post-test, and a p-value under
0.05 was considered statistically significative.

Molecules 2019, 24, 3484
11 of 13
3.6. Molecular Dynamic (MD) Simulations Assay
Molecular dynamic (MD) simulations used to study the interaction mechanism between 7c, 8c,
and membranes were performed according to Forero-Doria et al., 2018 [26]. The two salts were placed
in a periodically repeating box containing explicit TIP3P [36], defined as water molecules with a
pre-equilibrated phosphatidyl oleoyl phosphatidylcholine (POPC) bilayer in a periodic boundary
condition box (45 Å
×
55 Å
×
95 Å3). The SCHRÖDINGER suite with an OPLS v2005 force field [37
]
was used for the MD simulation. The POPC lipid bilayer, composed of 96 lipids (48 per monolayer),
was hydrated on each side by 20 Å water slabs. Ligands were immersed in the TIP3P water by
placing each molecule at 10 Å from the lipid bilayer. Systems were energy minimized (5000 steps),
equilibrated for 1 ns, and simulated for 40 ns. Periodic boundary conditions were implemented in both
systems. The MD simulation was performed at constant temperature (300 K) and pressure (1.01325 bar)
values, with an isothermal-isobaric ensemble (NPT-Ensemble). The MD simulation was run for 40 ns,
the motion equations were integrated with 2 fs, and the data were collected every 40 ps of the trajectory.
Finally, the MDS was analyzed using the VMD software [38].
4. Conclusions
A series of novel N-alkylimidazolium salts functionalized with cinnamic and p-coumaric acid with
different chain lengths were synthesized using a mechanochemistry approach. The synthesized salts
showed good antibacterial activity against Gram-positive bacteria (chain length of 8 and 10 carbons),
and activity that decreased against the studied Gram-negative bacteria, and a better antibacterial effect
was found when an OH group was presented in the structure of the salt, as observed in the salt 8c
,
which presented the best MIC value against S. epidermidis and S. aureus. However, when the antibiofilm
activity was studied, no significant differences were found among the salts derived from p-coumaric,
highlighting the salts derived from cinnamic acid, especially the inhibition of the formation of biofilm of
S. aureus, with about 52% inhibition. The MD simulations showed that the salts derived from cinnamic
acid were highly mobile compared with the salts derived from coumaric acid; nevertheless, the salts
derived from p-coumaric acid showed a more stable interaction with the membrane, explaining, in part,
the better antibacterial activity when the OH group was present. These findings, along with the MD
simulations analysis, suggest that the salts derived from p-coumaric acid with chain lengths of 8 and
10 carbons are good alternatives as antibacterial compounds, but the salt derived from cinnamic acid
with an alkyl chain of 8 carbons could be a good alternative as an antibiofilm compound against
infections caused by S. aureus.
Supplementary Materials: The following are available online, Figures S1–S16 are 1H and 13C NMR spectrums,
Videos S1–S2: MD simulations of compounds 7c and 8c, respectively.
Author Contributions: L.G. and O.F.-D. conceived and designed the experiments and wrote the first draft of
the manuscript. R.A.-M. supervised the study and reviewed manuscript. O.F.-D. and A.B.-R. contributed to the
experiments and L.M.-Q. performed the molecular dynamics simulations. All authors analyzed and interpreted
data, drafted the paper, and read and approved the final manuscript.
Funding: FONDECYT Post-Doctoral Fellowship N◦ 3170757; FONDECYT Initiation N◦ 11150390.
Acknowledgments: Luis Guzmá
n thanks FONDECYT (FONDECYT Initiation N◦ 11150390), and Oscar
Forero-Doria thanks FONDECYT (Post-Doctoral Fellowship No.3170757). The authors are grateful to Conrado
Camilo Manriquez of the Direcci
ó
n de Investigaciones Cient
í
ficas y Tecnol
ógicas de la Pontificia (DICTUC), Center
of Aromas and Flavors of the Pontificia Universidad Cat
ó
lica de Chile, for the realization and analysis of the
mass spectra.
Conflicts of Interest: The authors declare no conflicts of interest.

Molecules 2019, 24, 3484
12 of 13
References
1.
Messali, M.; Moussa, Z.; Alzahrani, A.Y.; El-Naggar, M.Y.; El Douhaibi, A.S.; Judeh, Z.M.A.; Hammouti, B.
Synthesis, characterization and the antimicrobial activity of new eco-friendly ionic liquids. Chemosphere 2013
,
91, 1627–1634. [CrossRef] [PubMed]
2.
Jiao, J.; Gai, Q.-Y.; Fu, Y.-J.; Zu, Y.-G.; Luo, M.; Zhao, C.-J.; Li, C.-Y. Microwave-assisted ionic liquids treatment
followed by hydro-distillation for the efficient isolation of essential oil from Fructus forsythiae seed. Sep. Purif.
Technol. 2013, 107, 228–237. [CrossRef]
3.
4.
5.
6.
7.
8.
9.
Romero, A. L
Rev. R. Acad. Cienc. Exact. Fís. Nat. 2008, 102, 79–90.
Petkovic, M.; Seddon, K.R.; Rebelo, L.P.N.; Silva Pereira, C. Ionic liquids: A pathway to environmental
acceptability. Chem. Soc. Rev. 2011, 40, 1383–1403. [CrossRef] [PubMed]
Shamshina, J.L.; Barber, P.S.; Rogers, R.D. Ionic liquids in drug delivery. Expert Opin. Drug Deliv. 2013, 10,
1367–1381. [CrossRef] [PubMed]
Malhotra, S.V.; Kumar, V. A profile of the in vitro anti-tumor activity of imidazolium-based ionic liquids.
Bioorg. Med. Chem. Lett. 2010, 20, 581–585. [CrossRef] [PubMed]
Blesic, M.; Marques, M.H.; Plechkova, N.V.; Seddon, K.R.; Rebelo, L.P.N.; Lopes, A. Self-aggregation of ionic
liquids: Micelle formation in aqueous solution. Green Chem. 2007, 9, 481–490. [CrossRef]
Pernak, J.; Skrzypczak, A.; Lota, G.; Frackowiak, E. Synthesis and Properties of Trigeminal Tricationic Ionic
Liquids. Chem. Eur. J. 2007, 13, 3106–3112. [CrossRef] [PubMed]
íquidos Iónicos a Temperatura Ambiente: Un Nuevo Medio para las Reacciones Químicas.
Łuczak, J.; Jungnickel, C.; Ła˛cka, I.; Stolte, S.; Hupka, J. Antimicrobial and surface activity of
1-alkyl-3-methylimidazolium derivatives. Green Chem. 2010, 12, 593–601. [CrossRef]
´
10. Vraneš, M.; Tot, A.; Cosic´, J.; Papovic´, S.; Panic´, J.; Gadžuric´, S.; Jankovic´, N.; Vrandecˇic´, K. Correlation
between lipophilicity of newly synthesized ionic liquids and selected Fusarium genus growth rate. RSC Adv.
2019, 9, 19189–19196. [CrossRef]
11. Pendleton, J.N.; Gilmore, B.F. The antimicrobial potential of ionic liquids: A source of chemical diversity for
infection and biofilm control. Int. J. Antimicrob. Agents 2015, 46, 131–139. [CrossRef] [PubMed]
12. Dryden, M.S. Skin and soft tissue infection: Microbiology and epidemiology. Int. J. Antimicrob. Agents 2009
34 Suppl 1, S2–S7. [CrossRef]
,
13. Barie, P.S.; Wilson, S.E. Impact of Evolving Epidemiology on Treatments for Complicated Skin and Skin
Structure Infections: The Surgical Perspective. J. Am. Coll. Surgeons 2015, 220, 105–116. [CrossRef] [PubMed]
14. Jamal, M.; Ahmad, W.; Andleeb, S.; Jalil, F.; Imran, M.; Nawaz, M.A.; Hussain, T.; Ali, M.; Rafiq, M.;
Kamil, M.A. Bacterial biofilm and associated infections. J. Chin. Med. Assoc. 2018, 81, 7–11. [CrossRef]
[PubMed]
15. Nazar, J. Biofilms bacterianos. J. Nazar. 2007, 67, 161–172. [CrossRef]
16. Sharma, P. Cinnamic acid derivatives: A new chapter of various pharmacological activities. J. Chem.
Pharm. Res. 2011, 3, 403–423.
17. Mussatto, S.I.; Dragone, G.; Roberto, I.C. Ferulic and p-coumaric acids extraction by alkaline hydrolysis of
brewer’s spent grain. Ind. Crop. Prod. 2007, 25, 231–237. [CrossRef]
18. Chen, Y.-L.; Huang, S.-T.; Sun, F.-M.; Chiang, Y.-L.; Chiang, C.-J.; Tsai, C.-M.; Weng, C.-J. Transformation
of cinnamic acid from trans- to cis-form raises a notable bactericidal and synergistic activity against
multiple-drug resistant Mycobacterium tuberculosis. Eur. J. Pharm. Sci. 2011, 43, 188–194. [CrossRef]
[PubMed]
19. Sova, M. Antioxidant and antimicrobial activities of cinnamic acid derivatives. Mini Rev. Med. Chem. 2012
12, 749–767. [CrossRef]
,
20. Lou, Z.; Wang, H.; Rao, S.; Sun, J.; Ma, C.; Li, J. p-Coumaric acid kills bacteria through dual damage
mechanisms. Food Control 2012, 25, 550–554. [CrossRef]
21. Turner, L.B.; Mueller-Harvey, I.; McAllan, A.B. Light-induced isomerization and dimerization of cinnamic
acid derivatives in cell walls. Phytochemistry 1993, 33, 791–796. [CrossRef]
22. Patel, V.; Ray, D.; Aswal, V.K.; Bahadur, P. Triton X-100 micelles modulated by solubilized cinnamic acid
analogues: The pH dependant micellar growth. Colloid Surface A 2014, 450, 106–114. [CrossRef]

Molecules 2019, 24, 3484
13 of 13
23. Cappelli, A.; Grisci, G.; Paolino, M.; Giuliani, G.; Donati, A.; Mendichi, R.; Artusi, R.; Demiranda, M.;
Zanardi, A.; Giorgi, G. Hyaluronan derivatives bearing variable densities of ferulic acid residues. J. Mat.
Chem. B 2014, 2, 4489–4499. [CrossRef]
24. Verma, S.K.; Ghorpade, R.; Pratap, A.; Kaushik, M.P. Solvent free, N,N0-carbonyldiimidazole (CDI) mediated
amidation. Tetrahedron Lett. 2012, 53, 2373–2376. [CrossRef]
25. Patil, P.R.; Ravindranathan Kartha, K.P. Application of Ball Milling Technology to Carbohydrate Reactions:
I. Regioselective Primary Hydroxyl Protection of Hexosides and Nucleoside by Planetary Ball Milling. J.
Carbohyd. Chem. 2008, 27, 279–293. [CrossRef]
26. Forero Doria, O.; Castro, R.; Gutierrez, M.; Gonzalez Valenzuela, D.; Santos, L.; Ramirez, D.; Guzman, L.
Novel Alkylimidazolium Ionic Liquids as an Antibacterial Alternative to Pathogens of the Skin and Soft
Tissue Infections. Molecules 2018, 23, 2354. [CrossRef]
27. Raya-Cruz, M.; Ferullo, I.; Arrizabalaga-Asenjo, M.; Nadal-Nadal, A.; D
Payeras-Cifre, A. Infecciones de piel y partes blandas en pacientes hospitalizados: Factores epidemiol
microbiol gicos, cl nicos y pron sticos. Enfermedades Infecciosas y Microbiolog a Cl nica 2014, 32, 152–159.
[CrossRef]
í
az-Antol
í
n, M.P.; Garau-Colom, M.;
ó
gicos,
ó
í
ó
í
í
28. Lewis, K. Riddle of biofilm resistance. Antimicrob. Agents Chemother. 2001, 45, 999–1007. [CrossRef]
29. Docherty, K.M.; Kulpa, J.C.F. Toxicity and antimicrobial activity of imidazolium and pyridinium ionic liquids.
Green Chem. 2005, 7, 185–189. [CrossRef]
30. Wei, Q.-Y.; Jiang, H.; Zhang, J.-X.; Zhang, C.; Guo, P.-F. Antimicrobial Activities of the Cinnamoyl Amide of
Amino Acid Derivatives. Asian J. Chem. 2012, 24, 2383–2388.
31. Santos, A.G.; Ribeiro, B.D.; Alviano, D.S.; Coelho, M.A.Z. Toxicity of ionic liquids toward microorganisms
interesting to the food industry. RSC Adv. 2014, 4, 37157–37163. [CrossRef]
32. Garcia, M.T.; Ribosa, I.; Perez, L.; Manresa, A.; Comelles, F. Self-assembly and antimicrobial activity of
long-chain amide-functionalized ionic liquids in aqueous solution. Colloid. Surface. B 2014, 123, 318–325.
[CrossRef]
33. Venkata, Y.; Reddy, G.K.; Lalithamanasa, P.; Venugopalan, V.P. The ionic liquid 1-alkyl-3-methylimidazolium
demonstrates comparable antimicrobial and antibiofilm behavior to a cationic surfactant. Biofouling 2012, 28,
1141–1149. [CrossRef]
34. Ferrer, M.D.; Rodriguez, J.C.;
Álvarez, L.; Artacho, A.; Royo, G.; Mira, A. Effect of antibiotics on biofilm
inhibition and induction measured by real-time cell analysis. J. Appl. Microbiol. 2017, 122, 640–650. [CrossRef]
35. Eloff, J.N. A sensitive and quick microplate method to determine the minimal inhibitory concentration of
plant extracts for bacteria. Planta Med. 1998, 64, 711–713. [CrossRef]
36. Jorgensen, W.L.; Chandrasekhar, J.; Madura, J.D.; Impey, R.W.; Klein, M.L. Comparison of simple potential
functions for simulating liquid water. J. Chem. Phys. 1983, 79, 926–935. [CrossRef]
37. Jorgensen, W.L.; Maxwell, D.S.; Tirado-Rives, J. Development and Testing of the OPLS All-Atom Force Field
on Conformational Energetics and Properties of Organic Liquids. J. Am. Chem. Soc. 1996, 118, 11225–11236.
[CrossRef]
38. Humphrey, W.; Dalke, A.; Schulten, K. VMD: Visual molecular dynamics. J. Mol. Graph. Model. 1996, 14,
33–38. [CrossRef]
Sample Availability: Not available.
©
2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).